NEW YORK, April 14 (Reuters) – After lagging a six-year
healthcare sector run fueled by fast-growing biotech companies,
Johnson & Johnson shares have beaten the group in 2016
as investors turn to…
The post Investors find safety in J&J shares, but run could stall appeared first on NASDAQ.